Novartis To Develop a Smart Inhaler
Novartis (AG) ADR (NYSE:NVS) and Qualcomm, Inc.’s (NASDAQ:QCOM) subsidiary Qualcomm Life, announced a collaboration regarding the development of Novartis’ Breezhaler inhaler device. It is a digital inhaler for patients suffering from chronic obstructive pulmonary disease (COPD). The Breezhaler (TM) inhaler will provide them compliance with the facility of accessing the data of their usage. It … Read more